VALIANTLAB

Valiant Laboratories Share Price Valiant Laboratories

₹146.4
-2.5 (-1.68%)
13 May, 2024 00:42 BSE: 543998 NSE: VALIANTLABISIN: INE0JWS01017

Start SIP in Valiant Laboratories

Start SIP

Valiant Laboratories Performance

Day Range

  • Low 145
  • High 150
₹ 146

52 Week Range

  • Low 139
  • High 215
₹ 146
  • Open Price150
  • Previous Close149
  • Volume53414

Valiant Laboratories Share Price

  • Over 1 Month -13.6%
  • Over 3 Month -19.76%
  • Over 6 Month -20.22%
  • Over 1 Year +4.57%

Valiant Laboratories Key Statistics

P/E Ratio 55
PEG Ratio -1.4
Market Cap Cr 636
Price to Book Ratio 6.3
EPS 6.7
Dividend 0
Relative Strength Index 33.66
Money Flow Index 68.1
MACD Signal -1.41
Average True Range 6.86
Valiant Laboratories Financials
IndicatorDec 2023Sep 2023Jun 2023
Oper Rev Qtr Cr 416051
Operating Expenses Qtr Cr 476148
Operating Profit Qtr Cr -6-14
Depreciation Qtr Cr 000
Interest Qtr Cr 000
Tax Qtr Cr -202
Net Profit Qtr Cr -414
IndicatorMar 2023
Total Revenue Annual Cr 339
Operating Expenses Annual Cr 299
Operating Profit Annual in Cr 35
Depreciation Cr 2
Interest Annual Cr 0
Tax Annual Cr 9
Net Profit Annual Cr 29
IndicatorMar 2023
Cash from Operating Activity Annual Cr 23
Cash from Investing Activity Annual Cr -21
Cash from Financing Annual Activity Cr -2
Net Cash Flow Annual Cr 0
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 100
Fixed Assets Annual Cr 30
Total Non Current Assets Annual Cr 31
Total Current Assets Annual Cr 182
Total Assets Annual Cr 213
IndicatorMar 2023
Book Value Per Share Annual Rs 31
ROE Annual % 29
ROCE Annual % 24
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 12
IndicatorDec 2023Sep 2023Jun 2023
Oper Rev Qtr Cr 416051
Operating Expenses Qtr Cr 476148
Operating Profit Qtr Cr -6-14
Depreciation Qtr Cr 000
Interest Qtr Cr 000
Tax Qtr Cr -202
Net Profit Qtr Cr -414
IndicatorMar 2023
Total Revenue Annual Cr 339
Operating Expenses Annual Cr 299
Operating Profit Annual in Cr 35
Depreciation Cr 2
Interest Annual Cr 0
Tax Annual Cr 9
Net Profit Annual Cr 29
IndicatorMar 2023
Cash from Operating Activity Annual Cr 56
Cash from Investing Activity Annual Cr -55
Cash from Financing Annual Activity Cr -1
Net Cash Flow Annual Cr 0
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 100
Fixed Assets Annual Cr 49
Total Non Current Assets Annual Cr 62
Total Current Assets Annual Cr 151
Total Assets Annual Cr 213
IndicatorMar 2023
Book Value Per Share Annual Rs 31
ROE Annual % 29
ROCE Annual % 24
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 12

Valiant Laboratories Technicals

EMA & SMA

Current Price
₹146.4
-2.5 (-1.68%)
pointer
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 13
  • 20 Day
  • ₹155.25
  • 50 Day
  • ₹160.06
  • 100 Day
  • ₹166.39
  • 200 Day
  • 20 Day
  • ₹157.42
  • 50 Day
  • ₹157.73
  • 100 Day
  • ₹169.93
  • 200 Day

Valiant Laboratories Resistance and Support

PIVOT
₹147.19
Resistance
First Resistance 149.22
Second Resistance 152.03
Third Resistance 154.07
RSI 33.66
MFI 68.10
MACD Single Line -1.41
MACD -2.49
Support
First Resistance 144.37
Second Resistance 142.33
Third Resistance 139.52

Valiant Laboratories Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 58,447 3,167,243 54.19
Week 97,872 6,053,383 61.85
1 Month 134,727 4,792,226 35.57
6 Month 239,538 12,326,627 51.46

Valiant Laboratories Result Highlights

Valiant Laboratories Synopsis

NSE-Medical-Whlsle Drg/Suppl

Valiant Laboratories belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 333.91 Cr. and Equity Capital is Rs. 32.56 Cr. for the Year ended 31/03/2023. Valiant Laboratories Ltd. is a Public Limited Listed company incorporated on 06/08/2021 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is U24299MH2021PLC365904 and registration number is 365904.
Market Cap 636
Sales 151
Shares in Float 1.09
No of funds 6
Yield
Book Value 4.74
U/D Vol ratio 0.6
LTDebt / Equity 59
Alpha -0.25
Beta 1.64

Valiant Laboratories

Owner NameMar-24Dec-23Oct-23Sep-23
Promoters 74.94%74.94%74.94%74.94%
Insurance Companies 0.02%0.04%0.04%
Foreign Portfolio Investors 3.48%7.08%8.64%8.64%
Individual Investors 15.16%13.36%12.49%12.49%
Others 6.42%4.6%3.89%3.89%

Valiant Laboratories Management

Name Designation
Mr. Velji Karamshi Gogri Chairman & Ind.Director
Mr. Santosh Shantilal Vora Managing Director
Mr. Shantilal Shivji Vora Non Executive Director
Mr. Paresh Shashikant Shah Executive Director
Ms. Sonal Amit Vira Independent Director
Mr. Sandeep Gupta Non Executive Director

Valiant Laboratories Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Valiant Laboratories Corporate Action

Date Purpose Remarks
2024-05-14 Audited Results
2024-02-09 Quarterly Results
2023-11-06 Quarterly Results

Valiant Laboratories MF Shareholding

Name Amount(cr)

Valiant Laboratories FAQs

What is Share Price of Valiant Laboratories ?

Valiant Laboratories share price is ₹146 As on 13 May, 2024 | 00:28

What is the Market Cap of Valiant Laboratories ?

The Market Cap of Valiant Laboratories is ₹636.1 Cr As on 13 May, 2024 | 00:28

What is the P/E ratio of Valiant Laboratories ?

The P/E ratio of Valiant Laboratories is 55 As on 13 May, 2024 | 00:28

What is the PB ratio of Valiant Laboratories ?

The PB ratio of Valiant Laboratories is 6.3 As on 13 May, 2024 | 00:28

Q2FY23